|
Oct 9
|
Applied DNA Sciences Inc (APDN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines ...
|
|
Sep 11
|
Applied DNA Launches Mpox Clade I and Clade II Testing Service
|
|
Sep 11
|
LRQA Teams With Applied DNA Sciences for Cotton Traceability Pilot in Pakistan
|
|
Sep 9
|
Applied DNA bags LRQA isotopic testing pilot project in Pakistan
|
|
Aug 23
|
US Equities Markets Close Higher Friday As Powell Hints Easing of Monetary Policy
|
|
Aug 23
|
Top Midday Gainers
|
|
Aug 8
|
Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates
|
|
Aug 8
|
Applied DNA Sciences: Fiscal Q3 Earnings Snapshot
|
|
Aug 8
|
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
|
|
Aug 7
|
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
|
|
Aug 1
|
Ball (BALL) Q2 Earnings Beat Estimates
|
|
Jul 31
|
Applied DNA’s CertainT Platform Gains Ground with Indus Group Deal
|
|
Jul 29
|
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
|
|
Jul 29
|
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
|
|
Jul 29
|
Applied DNA, Indus Group to scale cotton traceability
|
|
Jul 25
|
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
|
|
Jun 20
|
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
|
|
Jun 18
|
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
|
|
Jun 13
|
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
|
|
May 13
|
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
|